These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6443348)

  • 41. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
    Kayali A
    Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
    [No Abstract]   [Full Text] [Related]  

  • 42. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
    Gunasekara NS; Noble S
    Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Intraindividual dose-response relationship of sustained-release Elantan].
    Kenedi P
    Z Kardiol; 1986; 75 Suppl 3():77-9. PubMed ID: 3541420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
    Chernov SA; Tiurin VP; Gospodarenko AL; Kutepov IuS; Virs EA; Malenik OM
    Voen Med Zh; 1997 Apr; 318(4):39-41. PubMed ID: 9221593
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-acting isosorbide mononitrate.
    Prakash A; Markham A
    Drugs; 1999 Jan; 57(1):93-9; discussion 100. PubMed ID: 9951954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Quality of life and angina pectoris. Comparison of the effects of 2 nitrate derivatives administered discontinuously: transdermal 10 mg nitroglycerine patch (12 hours) and long-acting oral 40 mg isosorbide-5-mononitrate (once a day)].
    Marquis P; Le Gal M; Francillon A; André-Fouet X
    Ann Cardiol Angeiol (Paris); 2001 Oct; 50(6):340-50. PubMed ID: 12555626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris.
    Emanuelsson H; Ake H; Kristi M; Arina R
    Eur J Clin Pharmacol; 1989; 36(6):561-6. PubMed ID: 2506059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study.
    Brun J
    J Int Med Res; 1994; 22(5):266-72. PubMed ID: 7867871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical experience with Imdur in angina pectoris. A review.
    Nyberg G
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S65-8. PubMed ID: 1972359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An evaluation of the effects of isosorbide 5-mononitrate in patients with angina on effort using dynamic electrocardiography and echocardiography.
    Novo S; Nardi E; Alaimo G; Centineo G; Licata G; Strano A
    Cardiology; 1987; 74 Suppl 1():20-8. PubMed ID: 3300974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Anti-angina effectiveness of isosorbide dinitrate in an acute trial and following continuous 4-week therapy with 40 mg 6 times a day].
    Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
    Klin Wochenschr; 1985 May; 63(10):460-7. PubMed ID: 3925217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
    Chen YH; Ding PY; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
    Uberbacher HJ; Glocke M; Abshagen U
    MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
    [No Abstract]   [Full Text] [Related]  

  • 57. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
    Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
    Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of 50-mg and 100-mg sustained-release isosorbide mononitrate in the treatment of stable angina pectoris: effects on quality-of-life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group.
    Zwinderman AH; Cleophas TJ; van der Sluijs H; Niemeyer MG; Buunk BP; van der Wall EE
    Angiology; 1999 Dec; 50(12):963-9. PubMed ID: 10609762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of isosorbide-5-mononitrate on clinical condition, bicycle ergometry results, endothelium-dependent vasodilation in patients with ischemic heart disease with stable effort angina].
    Kazachkina SS; Balakhonova TV; Lupanov VP; Pogorelova OA; Rogoza AN; Naumov VG
    Ter Arkh; 2005; 77(10):71-5. PubMed ID: 16320691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent developments in the use of nitrates for treatment of angina pectoris.
    Ankier SI; Warrington SJ; Sneddon JM
    J Int Med Res; 1988; 16(4):249-56. PubMed ID: 3139481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.